Imaflex Announces the Appointment of Claude Plourde as Director Business Development - Sales Français
MONTREAL, Jan. 31, 2019 /CNW Telbec/ - Imaflex Inc. ("Imaflex" or the "Corporation") (TSXV: IFX), is pleased to announce the appointment of Claude Plourde to the newly created position of Director Business Development - Sales. In this role, Mr. Plourde will be responsible for identifying and developing new sales opportunities for the Corporation's core flexible packaging business.
Mr. Plourde is a seasoned sales executive, with extensive knowledge and expertise working in the packaging industry. He has a proven track record of forging strong business relationships and working closely with customers to deliver innovative, customized, value-added solutions.
"Claude will play a key role in expanding our customer base and driving business growth," highlighted Mr. Joe Abbandonato, President and Chief Executive Officer of Imaflex. "His relevant industry experience and large customer network, make him a great addition to the team and a natural fit for the position. He also joins us at an opportune time, with our impressive range of offerings and additional product possibilities made possible by the new coextrusion blown film line ("extruder")." The Corporation continues to expect the extruder to be installed and operational around the end of the first quarter of 2019.
Mr. Plourde has over 25 years of relevant experience, having previously worked with Hood Packaging and Emmerson Packaging (formerly PollyCello), where he was an integral part of their senior sales teams. Earlier in his career, he also worked in sales at Cryovac Sealed Air Canada.
About Imaflex Inc.
Founded in 1994, Imaflex is focused on the development and manufacturing of innovative solutions for the flexible packaging and agriculture industries. The Corporation's products consist primarily of polyethylene (plastic) film and bags, including metalized plastic film, for the industrial, agricultural and consumer markets. Headquartered in Montreal, Quebec, Imaflex has manufacturing facilities in Canada and the United States. The Corporation's common stock is listed on the TSX Venture Exchange under the ticker symbol IFX. Additional information is available at www.imaflex.com.
Cautionary Statement on Forward Looking Information
Certain information included in this press release constitutes "forward-looking" statements within the meaning of Canadian securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the management of the Corporation, are inherently subject to significant business, economic and competitive uncertainties, risks and contingencies. The Corporation cautions the reader that such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual financial results, performance or achievements of Imaflex to be materially different from the Corporation's estimated future results, performance or achievements expressed or implied by those forward-looking statements and that the forward-looking statements are not guarantees of future performance. These statements are also based on certain factors and assumptions. For more details on these estimates, risks, assumptions and factors, see the Corporation's most recent Management Discussion and Analysis filed on SEDAR at www.sedar.com and on the investor section of the Corporation's website at www.imaflex.com. The Corporation disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise, except as expressly required by law. Readers are cautioned not to put undue reliance on these forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Imaflex Inc.
Imaflex Contact: John Ripplinger, Vice-President Corporate Affairs, Tel: (514) 935-5710 ext. 157, Fax: (514) 935-0264, [email protected]
Share this article